Clinical trial Recruiting at 3 sites Observational Ages 16 and up

Aftercare for childhood cancer survivors in Switzerland

Official title: Aftercare of Childhood Cancer Survivors in Switzerland - the ACCS Switzerland Project

Run by Kantonsspital Aarau · NCT04284189 · Data updated 2026-11-12

This study is trying to find out how childhood cancer survivors in Switzerland feel about their follow-up care as they transition from pediatric to adult healthcare, so they can improve support for them.

More Survivorship trials

Quick facts

Study typeObservational
Ages16 Years and up
SexAll
Enrollment140 (estimated)
SponsorKantonsspital Aarau
Academic / other
Locations3 sites (Aarau and 2 other locations)
StatusRecruiting
StartedFebruary 12, 2019
Main results expectedApril 2025
Study endsAugust 2030
Registry record updatedAugust 17, 2022
Trial IDNCT04284189 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are individuals aged 16 and older who are at least 5 years post-treatment for childhood cancer and currently in follow-up care.

Probably not a fit

Patients who have undergone surgery only without increased risk of late effects or those with severe cognitive impairments may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

The Aftercare of Childhood Cancer Survivors in Switzerland (ACCS) study is a multicenter cohort investigation focused on the transition of follow-up care from pediatric oncology to adult care for adolescent and young adult survivors of childhood cancer. It aims to gather data on the preferences and expectations of these survivors regarding their follow-up care through questionnaires. The study addresses the critical need for effective transition strategies, as many survivors experience late effects from their treatment. By comparing different aftercare models, the study seeks to identify the best practices that meet the needs of these individuals.

Why it matters

Potential benefit: If successful, this study could improve the follow-up care and quality of life for childhood cancer survivors transitioning to adult care.

How similar studies have gone: While there have been studies on childhood cancer survivorship, this specific approach to comparing transition models is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 5-year survivor of childhood cancer
* Diagnosis according to ICCC3 I-XII; Langerhans cell histiocytosis (LCH), Hemophagocytic lymphohistiocytosis (HLH)
* Age at diagnosis \<18 years
* Age at study ≥16 years
* At study start in follow-up care at one of the three pediatric oncology centers (group before transition) or transitioned not before 2014 (group after transition).
* Written informed consent

Exclusion Criteria:

* Treatment only by means of surgery and without increased risk of late effects (e.g. teratoma)
* \<5 years after therapy of a relapse or palliative situation
* Severe cognitive impairment, which makes it impossible to complete the questionnaire independently
* Insufficient knowledge of the German language
* Informed consent form not signed

Where it's running

  • Division of Oncology - Hematology, Department of Pediatrics, Kantonsspital Aarau
    Aarau, Switzerland
    Recruiting
  • Division of Oncology/ Hematology, University Children's Hospital Basel
    Basel, Switzerland
    Recruiting
  • Division of Oncology/ Hematology, Department of Pediatrics, Kantonsspital Lucerne
    Lucerne, Switzerland
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.